Savara

Savara is a Texas-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of respiratory diseases.

Business Model:

Revenue: $257k

Employees: 11-50

Detailed Savara Information

Savara was acquired by Mast Therapeutics.
The acquisition happend on 2017-01-09.
Details of the transaction were not public

Geographic Data

Savara headquarters map

Address: 6836 Bee Cave Road

City: Austin

State: TX

Zip: 78746

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$27M

Raised Total:

$237M

Metrics

4,846,075Website Global Rank

1,841Website Monthly Traffic

Twitter Followers

Description

Savara is a Texas-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of respiratory diseases.

Contact Phone:
+15126141848

Contact Email:

Savara went public on 6/1/2017 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/1/2017

IPO Valuation:
$111M

Ticker Symbol:
SVRA

IPO Price:
$4.75/share

Amount Raised:
$40M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Name Price
6/2016 Serendex Pharmaceuticals

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research